Seeking males & females 1-31 years of age who have completed induction therapy for B Lymphoblastic Leukemia (B-ALL) & it has has been classified as a very high risk B-ALL (VHR B-ALL).
The overall goals are to are to determine end of Consolidation disease status and better understand the effects of cancer treatment in people with VHR B-ALL.
What we're hoping for
We are hoping that an assessment of Minimal Residual Disease Evaluation (MRD), which may help determine the treatment options following Consolidation therapy.
ClinicalTrials.gov Identifier: NCT02883049